Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options. (Q38904928)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27444275%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

review article

1 reference

title

Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27444275%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27444275%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Shawn Baldacchino

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27444275%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Christian Scerri

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27444275%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Christian Saliba

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27444275%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Maria Pia Grixti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27444275%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Robert Gauci

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27444275%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Vanessa Petroni

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27444275%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Anthony G Fenech

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27444275%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

publication date

21 July 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27444275%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27444275%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27444275%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27444275%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

11691-11700

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27444275%20AND%20SRC:MED&resulttype=core&format=json

Phosphatases: the new brakes for cancer development?

19 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Loss of PINK1 function decreases PP2A activity and promotes autophagy in dopaminergic cells and a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with alpha4 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Actions of PP2A on the MAP kinase pathway and apoptosis are mediated by distinct regulatory subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

The Raf/MEK/ERK pathway: new concepts of activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Identification of PP2A complexes and pathways involved in cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

PP2A regulatory subunit PP2A-B' counteracts S6K phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Protein phosphatase 2A (B55α) prevents premature activation of forkhead transcription factor FoxM1 by antagonizing cyclin A/cyclin-dependent kinase-mediated phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

PP2A:B56ϵ, a Substrate of Caspase-3, Regulates p53-dependent and p53-independent Apoptosis during Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Identification of the general transcription factor Yin Yang 1 as a novel and specific binding partner for S6 kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

PP2A: unveiling a reluctant tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Deregulation of the phosphatase, PP2A is a common event in breast cancer, predicting sensitivity to FTY720.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

PP2A inhibition is a common event in colorectal cancer and its restoration using FTY720 shows promising therapeutic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

alpha- and beta-forms of the 65-kDa subunit of protein phosphatase 2A have a similar 39 amino acid repeating structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

PP2A: the expected tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Generation of Ppp2Ca and Ppp2Cb conditional null alleles in mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Regulation of protein phosphatase 2A methylation by LCMT1 and PME-1 plays a critical role in differentiation of neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

The biogenesis of active protein phosphatase 2A holoenzymes: a tightly regulated process creating phosphatase specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

The structural basis for tight control of PP2A methylation and function by LCMT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Genenames.org: the HGNC resources in 2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

The PP2A-associated protein alpha4 is an essential inhibitor of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Determinants for Substrate Specificity of Protein Phosphatase 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Structure of the protein phosphatase 2A holoenzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Methylation of the protein phosphatase 2A catalytic subunit is essential for association of Balpha regulatory subunit but not SG2NA, striatin, or polyomavirus middle tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Circumventing cellular control of PP2A by methylation promotes transformation in an Akt-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Human cancer-associated mutations in the Aα subunit of protein phosphatase 2A increase lung cancer incidence in Aα knock-in and knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Alterations of the PPP2R1B gene in human lung and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

The tumor suppressor PP2A Abeta regulates the RalA GTPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Evaluation of PPP2R2A as a prostate cancer susceptibility gene: a comprehensive germline and somatic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Identification and characterization of an alternatively spliced isoform of the human protein phosphatase 2Aα catalytic subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Igbp1 is part of a positive feedback loop in stem cell factor-dependent, selective mRNA translation initiation inhibiting erythroid differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Novel pathway in Bcr-Abl signal transduction involves Akt-independent, PLC-gamma1-driven activation of mTOR/p70S6-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Targeting the BCR-ABL signaling pathway in therapy-resistant Philadelphia chromosome-positive leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Identification and characterization of SEB, a novel protein that binds to the acute undifferentiated leukemia-associated protein SET

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

CIP2A inhibits PP2A in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

CIP2A expression is increased in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Prognostic role of CIP2A expression in serous ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

CIP2A is a predictor of poor prognosis in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

CIP2A is associated with human breast cancer aggressivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

CIP2A is over-expressed in acute myeloid leukaemia and associated with HL60 cells proliferation and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Lipid phosphatases as drug discovery targets for type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Dual-specificity phosphatases as targets for antineoplastic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Protein tyrosine phosphatases: from genes, to function, to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Discovery and optimization of sulfonyl acrylonitriles as selective, covalent inhibitors of protein phosphatase methylesterase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Academic cross-fertilization by public screening yields a remarkable class of protein phosphatase methylesterase-1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Inhibition of protein methylesterase 1 decreased cancerous phenotypes in endometrial adenocarcinoma cell lines and xenograft tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Therapeutic Implications of Targeting AKT Signaling in Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

An update in management of noncutaneous T-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Apolipoprotein E and peptide mimetics modulate inflammation by binding the SET protein and activating protein phosphatase 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Effect of FTY720 on the SET-PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Targeting SET/I(2)PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

CIP2A is a target of bortezomib in human triple negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Ethoxysanguinarine Induces Inhibitory Effects and Downregulates CIP2A in Lung Cancer Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

A new role of protein phosphatase 2a in adenoviral E1A protein-mediated sensitization to anticancer drug-induced apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Carnosic acid modulates Akt/IKK/NF-κB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

PP2A-mediated regulation of Ras signaling in G2 is essential for stable quiescence and normal G1 length

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5145-4

Augmentation of methylprednisolone-induced differentiation of myeloid leukemia cells by serine/threonine protein phosphatase inhibitors

21 January 2018

1 reference

12 December 2020

Mechanism of activation of protein kinase B by insulin and IGF-1

1 reference

12 December 2020

Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms

1 reference

12 December 2020

Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression

1 reference

12 December 2020

Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin

1 reference

12 December 2020

Molecular model of the A subunit of protein phosphatase 2A: interaction with other subunits and tumor antigens

1 reference

12 December 2020

Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia

1 reference

12 December 2020

Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers -- Letter

1 reference

12 December 2020

Alterations of tumour suppressor gene PPP2R1B in hepatocellular carcinoma

1 reference

12 December 2020